Chicago Classification Normative Metrics in a Healthy Russian Cohort According to High-resolution Esophageal Manometry

NCT ID: NCT03829865

Last Updated: 2021-04-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-02-04

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

High resolution esophageal manometry normative values are still need to be studied in different populations and with the use of solid-state and water-perfused systems. There has been no study on the subject in healthy Russian population yet.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

High-resolution esophageal manometry (HREM) is the current modality used to evaluate esophageal motility. There are 2 types of system: water-perfused system that is cheaper to maintain and a solid-state system that is considered to be more sensitive. According to the data obtained in the study of 400 patients and 75 controls by J Pandolfino et al it was proposed to use a common algorithm of HREM data interpretation and the normative values of the parameters used to interpret the color plots of HREM. This formed the basis for the first version of the currently used HREM reporting algorithm and classification of esophageal motility disorders called Chicago Classification (CC). To date, this classification has been updated several times by the International Working Group based on the recently published data. The Working group stated that the proposed normative values still need to be widely studied for each HREM system and in different populations. Some studies has been published recently on the normative values of HREM in different countries (predominantly in the US, in some European countries, Korea, India and China. But there has been no study on the subject in Russia still.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Water-perfused HREM

Healthy volunteers examined with water-perfused high resolution esophageal manometry

High resolution esophageal manometry

Intervention Type DIAGNOSTIC_TEST

High resolution esophageal manometry will be performed to eligible subjects willing to participate in the study

Solid-state HREM

Healthy volunteers examined with high resolution esophageal manometry with solid-state catheter

High resolution esophageal manometry

Intervention Type DIAGNOSTIC_TEST

High resolution esophageal manometry will be performed to eligible subjects willing to participate in the study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High resolution esophageal manometry

High resolution esophageal manometry will be performed to eligible subjects willing to participate in the study

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Willingness to participate on the basis of signed informed consent form;
* Patients of both sexes, aged 18 to 65 years inclusive;
* Permanent residence in the Russian Federation;
* Absence of esophageal diseases, confirmed by the results of clinical and instrumental examination
* Ability to follow instructions during high-resolution esophageal manometry procedure

Exclusion Criteria

* diseases of the esophagus (any condition on the basis of clinical and / or instrumental examination, including: complaints of heartburn, belching, difficulty to swallow solid and/or liquid food;
* any surgical intervention on the gastrointestinal tract and / or chest organs in medical history;
* solid organ transplantation in medical history with the exception of a corneal transplant and surgery to replace the lens of the eye;
* any oncology of any localization except for skin cancer in situ in the medical history;
* any decompensated diseases of any organs and systems, which, in the opinion of the researcher, makes it impossible to carry out the procedure of esophageal manometry of high resolution or if the procedure may cause the risk of deterioration of the patient's condition;
* any condition, clinical and laboratory signs of alcohol abuse (abuse will be assessed in the case of male subjects consuming more than 30 g of pure alcohol per day and using more than 20 g of pure alcohol per day by female subjects;
* any illegal drug use, current or past;
* use of concomitant medications that can affect esophageal motility including, but not limited to: calcium channel blockers, metoclopramide, m-cholinolytics, domperidone, erythromycin, nitrates, tricyclic antidepressants, opiates, beta-blockers, beta-adrenomimetics, alcohol. The duration of the period of non-use of these drugs should provide sufficient time for the complete cessation of their pharmacological action, but not less than two half-life.
* pregnant or breastfeeding women
* any condition making impossible to perform high resolution esophageal manometry (previously known poor tolerability of the procedure; narrow nasal passages; significant curvature of the nasal septum etc).
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Russian Academy of Medical Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Vasily Isakov

MD, PhD, Professor, AGAF

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vasily Isakov, MD, PhD

Role: STUDY_CHAIR

Federal Research Center of Nutrition and Biotechnology

Sergey Morozov, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Federal Research Center of Nutrition and Biotechnology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gastroenterology and Hepatology, FRC Nutrition and Biotechnology

Moscow, , Russia

Site Status RECRUITING

Moscow clinical hospital #31

Moscow, , Russia

Site Status RECRUITING

Pavlov First Saint Petersburg State Medical University. Endoscopy Department

Saint Petersburg, , Russia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Russia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sergey Morozov, MD, PhD

Role: CONTACT

+74996131091

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sergey Morozov, MD, PhD

Role: primary

+74996131091

Valeria O Kaibysheva, MD, PhD

Role: primary

+79160206727

Alexandr A Smirnov, MD, PhD

Role: primary

+78005507225

Maya M Kiriltseva, MD, PhD

Role: backup

+78005507225

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OGIG-2019-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.